Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Corporate strategy stories

Nov 13, 2026

AstraZeneca cuts 600 US sales jobs in respiratory and immunology

AstraZeneca has eliminated approximately 600 positions from its US respiratory and immunology commercial teams as part of a three-year cost-savings initiative.

Nov 13, 2026·2 sources
00
Nov 10, 2026

AstraZeneca acquires vaccine biotech Omniose to bolster pipeline

AstraZeneca acquired early-stage US biotech Omniose, which is developing vaccines against serious bacterial infections, integrating it into its infectious diseases division.

Nov 10, 2026·2 sources
00
Nov 6, 2026

CVS Health breakup may preserve vertical integration despite regulatory scrutiny

An analysis finds that CVS Health's planned corporate breakup largely preserves the vertical integration model that has drawn political and regulatory criticism, raising questions about whether the restructuring will meaningfully change market dynamics.

Nov 6, 2026·2 sources
00
Nov 5, 2026

Siemens Healthineers begins carve-out of diagnostics business

Siemens Healthineers started carving out its diagnostics business, which it plans to rebrand as Olyrian Diagnostics ahead of a future divestment, and will rebrand the parent company as Healthineers.

Nov 5, 2026·2 sources
00
Nov 4, 2026

AstraZeneca made $10 billion offer for obesity drugmaker Rhythm Pharmaceuticals

AstraZeneca made a $10 billion takeover offer for Rhythm Pharmaceuticals, which specializes in treatments for metabolic conditions and severe obesity, according to sources familiar with the matter.

Nov 4, 2026·2 sources
00
Nov 3, 2026

CVS Health to split retail pharmacies from insurance operations

CVS Health announced it will break up its $117 billion healthcare conglomerate, separating its retail pharmacy business from its insurance and pharmacy-benefit operations in a reversal of its integrated care strategy.

Nov 3, 2026·4 sources
00
Nov 2, 2026

Fresenius signs biosimilars development agreement with WuXi Biologics

German healthcare company Fresenius has entered a partnership with China's WuXi Biologics to develop a pipeline of biosimilar drugs, expanding its presence in the biologics market.

Nov 2, 2026·3 sources
00
Oct 28, 2026

GSK shares fall after vaccine sales disappoint in Q3 results

GSK reported a drop in vaccine sales in its third quarter, sending shares down despite beating overall sales and profit expectations, as the UK drugmaker works to accelerate growth and prepare for patent expirations.

Oct 28, 2026·4 sources
00
Oct 26, 2026

Intel acquires quantum computing startup Classiq Technologies

Intel agreed to acquire Israeli quantum computing startup Classiq Technologies as part of its push to capitalize on quantum computing applications.

Oct 26, 2026·3 sources
00

GSK to nearly double cancer drugs in clinical trials by 2027

GSK expects to nearly double the number of cancer medicines it is testing in clinical trials next year, according to a Wall Street Journal interview with a company scientist. The expansion follows a dealmaking spree as the British drugmaker accelerates its return to oncology.

Oct 26, 2026·5 sources
00

Genmab's ovarian cancer drug cuts death risk 57% in late-stage trial

Genmab's experimental antibody-drug conjugate Rina-S reduced the risk of death by 57% compared to chemotherapy in patients with advanced ovarian cancer, according to phase 3 trial results presented at ESMO. The Danish drugmaker's shares surged over 12% on the news.

Oct 26, 2026·2 sources
00
Oct 21, 2026

Abbott Laboratories to spin off nutrition unit amid baby formula lawsuits

Abbott announced plans to separate its nutrition business, which includes Similac infant formula, into a publicly traded company. The unit has been at the center of years of litigation over management of a baby formula facility where deadly bacteria was found.

Oct 21, 2026·4 sources
00
Sep 20, 2026

Novo Nordisk cuts 13,000 jobs as CEO outlines strategy beyond weight-loss drugs

Novo Nordisk announced it cut 13,000 jobs in the past year and outlined plans to diversify beyond obesity drugs with new pipeline assets and bolt-on acquisitions. CEO Mike Doustdar faced investor skepticism about pricing power and strategy ahead of patent expiries.

Sep 20, 2026·9 sources
00
Aug 26, 2026

Biohaven licenses epilepsy drug platform to SK Biopharmaceuticals for up to $795 million

Biohaven Pharmaceuticals has entered into a licensing agreement with South Korean drugmaker SK Biopharmaceuticals for its epilepsy drug platform, including Opakalim, in a deal worth up to $795 million.

Aug 26, 2026·2 sources
00
Aug 18, 2026

Leo Pharma acquires worldwide rights to dersimelagon for up to $435M

Danish drugmaker Leo Pharma agreed to acquire worldwide rights to dersimelagon, a late-stage drug candidate for two rare genetic skin diseases, from Tanabe Pharma for up to $435 million in upfront and milestone payments.

Aug 18, 2026·2 sources
00
Aug 6, 2026

KKR Acquires Medicover India's 24-Hospital Network for $1.3 Billion

Global investment firm KKR has signed a definitive agreement to acquire Medicover India, the Indian hospital business of Stockholm-based Medicover, in a deal valued at approximately $1.3 billion (₹10,000-14,250 crore). The acquisition marks KKR's largest healthcare deal in India and includes a 24-hospital network, with plans for additional investment of ₹3,000-4,000 crore for expansion.

Aug 6, 2026·7 sources
00
Aug 3, 2026

Supernus Pharmaceuticals and Indivior Pharmaceuticals Agree to All-Stock Merger Creating $2.2 Billion CNS Drug Company

Supernus Pharmaceuticals and Indivior Pharmaceuticals announced an all-stock merger to create a combined company with approximately $2.2 billion in annual revenue and a portfolio of 11 commercialized medicines focused on neurological, psychiatric, and addiction-related conditions. The deal, described as a merger of equals, is expected to generate $125 million in cost savings.

Aug 3, 2026·9 sources
00
Jul 31, 2026

IBM CEO says quantum computing will contribute to revenue by 2028

IBM CEO Arvind Krishna stated the company expects quantum computing to measurably affect revenue and profit by 2028 or 2029, projecting $1 trillion in value from the technology by the end of the 2030s.

Jul 31, 2026·2 sources
00
Jun 16, 2026

Snap Launches $2,195 Consumer AR Glasses as CEO Defends Long-Term Strategy

Snap released its first consumer augmented-reality glasses priced at $2,195, positioning them as the future of AI-age interaction. CEO Evan Spiegel defended the product against activist investor pressure to shut down or spin off the hardware division.

Jun 16, 2026·2 sources
00
May 5, 2026

GameStop Makes $55.5 Billion Takeover Offer for eBay

Video game retailer GameStop offered to acquire eBay for $55.5 billion in an unsolicited bid that could turn hostile if rebuffed. The move would give GameStop control of a company four times its size.

May 5, 2026·2 sources
00

GameStop Proposes $55.5 Billion Unsolicited Bid to Acquire eBay

GameStop unveiled a non-binding $55.5 billion proposal to acquire eBay at $125 per share, a 46% premium, combining cash and stock in equal amounts.

May 5, 2026·4 sources
00

Top claims

  • ▪GSK Plc plans to relocate its research and development headquarters to Cambridge, United Kingdom, near AstraZeneca's global headquarters
  • ▪AstraZeneca pledged to invest $50 billion in the United States to expand manufacturing operations and generate tens of thousands of jobs
  • ▪Rival drugmaker GSK Plc is reducing costs to fund pipeline development before patent protection expires on an HIV drug before 2030

People involved

Josh HawleyMichael SenaRobert F. Kennedy Jr.Arvind Krishna

Subtopics

Mergers & acquisitions (M&A)10Pharmaceutical Industry10Corporate restructuring6Pharma5Drug development4Healthcare industry4Mergers and acquisitions4Clinical trials3Antitrust & competition2Biotech innovation2Biotechnology2Cancer & Oncology2Congress2Corporate consolidation2E-commerce2Elizabeth Warren2Novo Nordisk2Pharmaceutical patents2Pharmacy benefit managers2Quantum computing2Rare diseases2Retail industry2Stock market performance2Weight loss drugs2

Related timelines

Congress

110 stories

Crypto hacks

100 stories

Iran War

209 stories

Payments

118 stories

Russia-Ukraine war

136 stories